Skip to main content
. 2023 Mar 15;14:1067973. doi: 10.3389/fphar.2023.1067973

TABLE 7.

Defined daily dose per 1,000 inhabitants per day of antibiotics for systemic in the outpatient setting before (2019) and during the pandemic period (2020) in HSAL Doboj Region per year.

Groups of antibiotics INN ATC Antibiotic use at HSAL Doboj (DDD/100 patient-days) Relative rate of change*
2019 2020
Penicillins Phenoxymethylpenicillin J01CEO2 0.53 0.41 0.77
Amoxicillin J01CA04 4.49 3.91 0.87
Ampicillin po J01CA01 0.63 0.18 0.29
Ampicillin pe 0.05 0.05 1.09
Amox/clav po J01CR02 1.50 1.82 1.22
Amox/clav pe 0.00 0.01 2.57
Total 7.19 6.38 0.89
Cephalosporins Cefalexin JO1DB01 0.77 0.89 1.17
SUM first generation 0.77 0.89 1.17
Cefuroxime po J01DC02 0.36 0.37 1.03
Cefuroxime pe 0.00 0.00 0.63
Cefaclor J01DC04 0.02 0.01 0.52
SUM second generation 0.38 0.38 1.00
Cefixime po J01DD08 0.09 0.15 1.62
Cefpodoxime J01DD13 0.03 0.03 1.01
Ceftriaxone J01DD04 0.11 0.18 1.60
SUM third generation 0.23 0.36 1.54
Total 1.38 1.63 1.18
Macrolides Azithromycin po J01FA10 0.66 1.18 1.77
Azithromycin pe 0.00 0.00
Erythromycin J01FA01 0.19 0.06 0.32
Clarithromycin po J01FA09 0.22 0.18 0.81
Clarithromycin pe 0.00 0.00
Roxithromycin J01FA06 0.00 0.00 0.35
Total 1.07 1.42 1.32
Quinolones Ciprofloxacin po J01MA02 0.46 0.41 0.90
Ciprofloxacin pe 0.00 0.01 1.65
Levofloxacin J01MA12 0.14 0.24 1.74
Moxifloxacin po J01MA14 0.01 0.01 0.94
Moxifloxacin pe 0.00 0.00 6.65
Norfloxacin J01MA06 0.46 0.37 0.81
Total 1.07 1.05 0.98
Others Doxycycline J01AA02 0.64 0.41 0.63
TMS J01EE01 0.54 0.27 0.50
Lincomycin po J01FF02 0.10 0.06 0.56
Lincomycin pe 0.00 0.00 1.26
Clindamycin po J01FF01 0.04 0.04 1.05
Clindamycin pe 0.00 0.00 4.67
Gentamicin J01GB03 0.68 0.92 1.34
Nitrofurantoin J01XE01 0.12 0.23 1.74
Metronidazole po J01XD01 0.91 1.05 1.16
Metronidazole pe 0.01 0.12 0.11
Total 2.40 2.67 1.11
Total All INN

DDD/TID—defined daily dose per 1,000 inhabitants per day; INN, International Non-proprietary Name. *relative rate of change is calculated (DDD/TID 2020/DDD/TID 2019); po, per oral; pe parenteral.